Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$763K Sell
2,106
-10
-0.5% -$3.42K 0.17% 100
2026
Q1
$745K Sell
2,116
-23
-1% -$8.2K 0.21% 95
2025
Q4
$700K Hold
2,139
0.19% 98
2025
Q3
$636K Buy
2,139
+30
+1% +$8.7K 0.18% 102
2025
Q2
$626K Sell
2,109
-85
-4% -$24.1K 0.19% 100
2025
Q1
$684K Sell
2,194
-23
-1% -$6.79K 0.24% 92
2024
Q4
$592K Buy
2,217
+220
+11% +$65.3K 0.2% 98
2024
Q3
$643K Sell
1,997
-50
-2% -$16.4K 0.24% 94
2024
Q2
$640K Buy
2,047
+50
+3% +$14.7K 0.25% 86
2024
Q1
$568K Buy
+1,997
New +$584K 0.23% 96

Other funds holding AMGN

Umpqua Bank's AMGN Position: Q2 2026 in Review

Umpqua Bank reduced its Amgen (AMGN) stake by 0.47% in Q2 2026, selling an estimated $3.42K and leaving 2,106 shares worth $763K. The position accounts for 0.17% of the portfolio, ranked #100.

Umpqua Bank first reported a position in AMGN in Q1 2024 and has held it in 10 quarters since. 3,105 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Umpqua Bank held 2,106 shares of Amgen worth $763K as of Q2 2026.
  • Umpqua Bank sold 10 Amgen shares in Q2 2026, an estimated $3.42K.
  • Amgen made up 0.17% of Umpqua Bank's portfolio in Q2 2026, its #100 holding.
  • Umpqua Bank first reported a position in Amgen in Q1 2024 and has held it in 10 quarters since.
  • 3,105 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Umpqua Bank's 13F filing for Q2 2026, filed 24 Jul 2026.